Source / episode info
- **Episode:**609
- **Title:**DIP Ep 609: ANS Drugs For Step 2 and 3 (Very HY)
- **Published:**2025-06-10
- Source:Episode page
One-liner
This episode provides a deep dive into the pharmacology of the Autonomic Nervous System (ANS), covering the distinct actions of adrenergic receptors (_1, _1, _2, _2) and cholinergic receptors (Muscarinic, Nicotinic), along with high-yield drug applications for cardiovascular, respiratory, and urinary systems.
High-yield summary
- _1 Receptors: Located on blood vessels (causing vasoconstriction afterload) and the bladder neck; agonists increase BP/resistance, while blockers (e.g., Prazosin) are used for BPH and PTSD nightmares.
- _1 Receptors: Primarily found in the heart, increasing heart rate and contractility; they also stimulate renin release from juxtaglomerular cells.
- Cholinergic Crisis: Caused by excess acetylcholine (e.g., organophosphate poisoning); treated with Atropine (Muscarinic antagonist) followed by Pralidoxime (reactivates acetylcholinesterase).
- _2 Agonists: Drugs like Brimonidine and Apraclonidine reduce intraocular pressure (IOP) in glaucoma by stimulating _2 receptors.
- Anticholinergics: Block muscarinic receptors; common side effects include dry mouth, urinary retention, constipation, and can precipitate delirium.
- Blockers: Used for rate control in atrial fibrillation/flutter, reducing portal pressure (varices), and treating essential tremors or migraines.
Learning objectives
- Differentiate the physiological effects of \alpha_1, \beta_1, \beta_2, Muscarinic, and Nicotinic receptors.
- Select appropriate adrenergic or cholinergic agents for specific clinical scenarios (e.g., BPH, glaucoma, septic shock).
- Recognize the signs and management of drug toxicity related to ANS overstimulation/understimulation (e.g., Cholinergic Crisis, Anticholinergic Toxicity).
- Understand the mechanism and indications for various classes of \beta-blockers (selective vs. non-selective) and their use in heart failure or tremor.
Board exam buzzwords